FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.23  |  FHIR Version n/a  User: [n/a]

40759511000001103: Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Aug 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2315461000001115 Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2315471000001113 Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has AMP Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Is a Tapentadol 250mg modified-release capsules 56 capsule true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has specific active ingredient Tapentadol phosphate true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tapentadol true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has dispensed dose form Modified-release oral capsule true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start